Status:
COMPLETED
To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.
Lead Sponsor:
Ain Shams University
Conditions:
End Stage Renal Disease
Hemodiafiltration
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Removal of uremic toxins is the main goal of HD, It was improved by using high volume convective technique with high flux (HF) dialyzer. This technique removes medium - large molecular weight solutes ...
Eligibility Criteria
Inclusion
- Prevalent HD patients on regular hemodialysis sessions for \>6 months 3 sessions/week of 4 hours duration.
- Patients with Arterio-venous fistula as dialysis access.
Exclusion
- Patients with hemodialysis catheters.
- Patients with active inflammation or infection.
- Decompensated heart failure.
- Liver Cell Failure ( Child B,C)
- Patients with known malignancies.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04747067
Start Date
February 1 2021
End Date
September 1 2021
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospitals
Cairo, Governorate, Egypt, 0000